Sabby Management’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-76,000
Closed -$773K 98
2019
Q4
$773K Sell
76,000
-7,333
-9% -$43K 0.21% 24
2019
Q3
$442K Hold
83,333
0.24% 43
2019
Q2
$429K Hold
83,333
0.54% 35
2019
Q1
$646K Sell
83,333
-3,910
-4% -$30.4K 0.31% 25
2018
Q4
$150K Buy
87,243
+32,725
+60% +$124K 0.03% 77
2018
Q3
$405K Buy
54,518
+21,539
+65% +$186K 0.05% 79
2018
Q2
$366K Sell
32,979
-50,314
-60% -$612K 0.06% 89
2018
Q1
$843K Sell
83,293
-40
-0% -$540 0.1% 74
2017
Q4
$1.27M Sell
83,333
-94
-0.1% -$1.6K 0.12% 64
2017
Q3
$1.46M Sell
83,427
-2,263
-3% -$39.9K 0.1% 64
2017
Q2
$1.82M Buy
+85,690
New +$4.73M 0.12% 72
2016
Q1
Sell
-114
Closed -$77K 328
2015
Q4
$77K Sell
114
-1,145
-91% -$841K ﹤0.01% 302
2015
Q3
$856K Sell
1,259
-48
-4% -$36.5K 0.04% 253
2015
Q2
$1.14M Sell
1,307
-1,570
-55% -$1.85M 0.04% 213
2015
Q1
$4.75M Sell
2,877
-700
-20% -$1.25M 0.2% 83
2014
Q4
$5.44K Buy
3,577
+598
+20% +$1.09M 0.17% 67
2014
Q3
$6.08K Buy
+2,979
New +$7.86M 0.23% 55
2014
Q1
Sell
-523
Closed -$1.04M 263
2013
Q4
$1.04M Buy
+523
New +$1.11M 0.07% 116

Other funds holding MBOT

Sabby Management's MBOT Position: Q1 2020 in Review

Sabby Management sold out of Microbot Medical (MBOT) in Q1 2020, closing a stake of 76,000 shares — an estimated $773K sold.

Sabby Management first reported a position in MBOT in Q4 2013 and held it in 18 quarters. The position peaked at $4.75M in Q1 2015. 29 funds tracked by Wall St. Rank hold MBOT as of Q1 2020.

  • Sabby Management reported no remaining Microbot Medical position as of Q1 2020 after selling out during the quarter.
  • Sabby Management sold 76,000 Microbot Medical shares in Q1 2020, an estimated $773K.
  • Sabby Management first reported a position in Microbot Medical in Q4 2013 and held it in 18 quarters.
  • Sabby Management's Microbot Medical position peaked at $4.75M in Q1 2015.
  • 29 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2020.

Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.